Nass Valley Gateway Ltd. is pleased to announce that following the conditional CSE approval of the fundamental change announced on March 1, 2019, and further to the news release dated March 13, 2019, on March 18, 2019 the Company has issued 280,000,000 common shares as total consideration for its acquisition of Advanced Bioceuticals Limited and [...]
Nass Valley Gateway Ltd. is pleased to announce that NVG and the shareholders of its acquisition target, Advanced Bioceuticals Limited have agreed to amend the original "Definitive Acquisition and Share Exchange Agreement" dated for reference March 22, 2018 to increase the per share value and to decrease the number of Nass Valley's shares to be [...]
Nass Valley Gateway Ltd. regretfully wishes to announce that Mr. James Elliott who was elected at the Company's Annual General Meeting on December 12, 2018 as additional member of the Company's Board of Directors, resigned for personal reasons. Mr. Peter, President and CEO of Nass Valley states that Mr. Elliott had been elected for his valuable [...]
Nass Valley Gateway Ltd. is pleased to announce that following an internal Listing Application Review, the Canadian Securities Exchange has approved the fundamental change of Nass Valley Gateway Ltd. for listing subject to the following conditions: Completion of the acquisition of Advanced Bioceuticals Limited ; Completion of any and all [...]
In the news release, Nass Valley Gateway Ltd. - Corporate Update, issued 14-Dec-2018 by Nass Valley Gateway Ltd. over Cision, we are advised by the company that the first instance of Dieter Peter in the first paragraph has been changed to Milo Filgas. The complete, corrected release follows: Nass Valley Gateway Ltd. - Corporate Update Trading [...]
Nass Valley Gateway Ltd. wishes to announce that at its Annual General Meeting held on Wednesday, December 12, 2018, Messrs. Dieter Peter, Eric Peter-Kaiser, Andrew von Kursell, and Dieter Peter, were re-elected as Directors of Nass Valley. Mr. James Elliott was elected as additional Member of the Company's Board of Directors of the Company. The [...]
Nass Valley Gateway Ltd. is pleased to announce that, on March 22, 2018, it executed the Definitive Acquisition and Share Exchange Agreement with Advanced Bioceutical Limited, a privately owned Limited Liability Company incorporated under the Laws of New Jersey. Under the terms of the agreement ABL and its wholly owned subsidiary Pro-Thotics [...]
Nass Valley Gatewa wishes to announce that it has terminated the agreements with IXI Treasury Holdings Ltd. and IXI Ventures PLC which were announced by the Company on March 2, 2017 and September 27, 2017 respectively as the requested financial statements, audited by a qualified international audit firm, to verify the to be acquired assets, were [...]
Nass Valley Gateway wishes to announce that it has entered into a letter agreement granting the Company an exclusive right to acquire S.R. Hadden Industries which is actively engaged in the research and development of transdermal delivery systems through a third party and plans to first develop patches suitable for the delivery of [...]
Nass Valley Gateway wishes to announce that the letter agreement first announced in the Company's October 16, 2014 news release has expired. The LOI, which was subject to a Due Diligence Period and the approval of the Regulatory Authorities, provided Nass Valley the exclusive right to acquire a corporation actively involved in the medicinal [...]
Nass Valley Gateway is pleased to announce that its Board of Directors has agreed to settle an aggregate of $273,902 of indebtedness owed to Mineral Hill Industries, Merfin Management and Mr. Stuart Jackson in the amounts of $25,000, $195,000 and $3,902, respectively. The settlements come as the Company continues its due process to acquire the [...]
Nass Valley Gateway wishes to announce that it has entered into a letter agreement granting the Company an exclusive right to acquire a corporation which is actively involved in the medicinal cannabis industry. The Corporation has been involved in the medical cannabis field for over 4 years and currently works with registered physicians within [...]
